Electrophysiology dominates atrial fibrillation with PFA tech

Pulsed subject ablation (PFA) know-how has been dominating the electrophysiology market.

In response to key opinion leaders (KOLs) from Europe, most docs now favor to make use of PFA catheters over conventional ablation strategies, which usually embrace thermal or cryo power, due to PFA’s capability to create lesions nonthermally and inside milliseconds.

PFA catheters are solely commercially accessible in Europe. Nonetheless, the variety of sufferers handled with these catheters in Europe alone skilled a compound annual development fee (CAGR) of 254% from 2021 to 2023.

At present, solely two PFA methods are commercially accessible—Boston Scientific’s Farapulse and Medtronic’s Affera Mapping Programs. Biosense Webster can be attempting to enter this profitable market with its personal PFA system, the Veripulse. Nonetheless, in contrast to the opposite two catheters, the Veripulse has not but acquired any type of regulatory approval and remains to be within the early phases of medical trials.

PFA catheters are indicated to deal with atrial fibrillation (Afib) throughout electrophysiology procedures. Curiously, one other system, Boston Scientific’s Watchman FLX, which is used throughout left atrial appendage occlusion (LAAO) procedures, has been shaking up the Afib house. Between 2018 and 2022, the variety of sufferers implanted with a Watchman FLX grew by virtually 234%.

Nonetheless, regardless of this aggressive CAGR, electrophysiology procedures nonetheless far exceed the variety of LAAO procedures. The electrophysiology market nonetheless had the very best share by way of the variety of Afib therapy procedures, at 52% in 2022. PFA applied sciences are the present market chief and most most well-liked therapy for Afib within the electrophysiology house.